./../images/scitadlogo.png
 CitAD / S-CitAD
 Citalopram / Escitalopram for Agitation in Alzheimer's Disease 
The CitAD Research Group studies agitation in Alzheimer's diseaseS-CitAD Investigators
CitAD Trial Documents

CitAD PROTOCOL
CitAD DATA COLLECTION FORMS

FormForm NameRevision Date
ADActivities of Daily Living Inventory27-Oct-11
BCBlood Collection11-Aug-09
BNBlood Specimen Shipment Notification27-Oct-11
CACaregiver Information11-Aug-09
CGClinical Global Impression of Change11-Aug-09
CMCohen-Mansfield Agitation Inventory11-Aug-09
CSCornell Scale for Depression in Dementia 11-Aug-09
CWClinical Global Impression of Change Worksheet11-Aug-09
DRDeath Report11-Aug-09
ECEligibility and Enrollment Checklist27-Oct-11
EHEnrollment Medical History07-Jan-11
EPElectrolyte Panel Results27-Oct-11
ESEligibility Summary01-Dec-11
FCFollow-up Visit Checklist27-Oct-11
FHFollow-up Medical History26-Jan-10
GUGet Up and Go11-Aug-09
MSMini-Mental State Examination08-Oct-09
MVMissed or Incomplete Visit/Telephone17-Feb-11
NPNeuropsychiatric Inventory 11-Aug-09
NRNeurobehavioral Rating Scale 11-Aug-09
PLPatient and Caregiver Registration and Location11-Aug-09
QTQT Prolongation Monitoring27-Oct-11
SCStudy Participation Closeout27-Oct-09
SDStudy Drug Issue and Return13-Oct-10
SRSafety Report11-Aug-09
TCTelephone Contact11-Aug-09
TTTreatment Termination04-Feb-10
UEUnusual Event11-Aug-09

Questions? Please email us by clicking here© 2017,2018 The CitAD Research Group